Eisai Inc. has established a subsidiary in Brazil called Eisai Participações Ltda. (Eisai Brazil), which will be based in Sao Paulo. Eisai Brazil’s focus will be on establishing an initial infrastructure to support its operations into the Brazilian market. The company’s areas of commercial focus will include neurology, oncology and critical care.

“The establishment of Eisai Brazil marks our entry into Latin America,” said Hajime Shimizu, president, New Markets and ASEAN, Eisai Co., Ltd. “In keeping with Eisai’s human health care mission to satisfy unmet medical needs and contribute to the health and well-being of people worldwide, this expansion will enable us to introduce many of Eisai’s first-in-class products to people living in Brazil.”